Drug substance (API) and drug product development: We develop active pharmaceutical ingredients (APIs) and drug formulations, ensuring stability, bioavailability, and compliance.
Formulation development for various dosage forms (solids, liquids, semi-solids): Our expertise spans oral solids, sterile injectables, liquids, and semi-solids, tailored to specific therapeutic needs.
Intermediates development for clinical and commercial use: We also specialize in intermediates development, supporting clinical and commercial production with a robust library of compounds.